Richard Anderson
Stock Analyst at Wedbush
(3.53)
# 773
Out of 4,876 analysts
140
Total ratings
54.79%
Success rate
3.71%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HR Healthcare Realty Trust | Maintains: Neutral | $18 → $16 | $15.76 | +1.52% | 9 | May 5, 2025 | |
DOC Healthpeak Properties | Maintains: Outperform | $24 → $22 | $17.36 | +26.73% | 5 | Apr 28, 2025 | |
SAFE Safehold | Reiterates: Neutral | $20 | $15.76 | +26.90% | 5 | Apr 1, 2025 | |
NHI National Health Investors | Reiterates: Outperform | $88 | $70.84 | +24.22% | 4 | Mar 17, 2025 | |
CTRE CareTrust REIT | Reiterates: Underperform | $26 | $30.60 | -15.03% | 3 | Mar 14, 2025 | |
STRW Strawberry Fields REIT | Maintains: Outperform | $12 → $14 | $11.07 | +26.47% | 2 | Mar 5, 2025 | |
VTR Ventas | Maintains: Outperform | $69 → $78 | $62.88 | +24.05% | 7 | Feb 14, 2025 | |
WELL Welltower | Upgrades: Outperform | $145 → $167 | $152.13 | +9.77% | 5 | Feb 14, 2025 | |
UMH UMH Properties | Reiterates: Neutral | $20 | $16.73 | +19.55% | 4 | Jan 13, 2025 | |
DEI Douglas Emmett | Upgrades: Outperform | $19 → $21 | $15.19 | +38.25% | 2 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $81 → $70 | $68.60 | +2.04% | 5 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $33 | $32.28 | +2.23% | 3 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $72 | $60.06 | +19.88% | 1 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $110 | $73.37 | +49.93% | 7 | Dec 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $209 | $167.55 | +24.74% | 5 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $34.51 | +15.91% | 3 | Sep 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $118 → $131 | $113.76 | +15.15% | 4 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $68 → $75 | $67.35 | +11.36% | 5 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $264 → $301 | $285.41 | +5.46% | 8 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $49 | $40.71 | +20.36% | 4 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $45 | $36.20 | +24.31% | 3 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $33 | $27.77 | +18.83% | 3 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $154 → $184 | $147.85 | +24.45% | 4 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $15.76 | +39.59% | 2 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $17 | $10.53 | +61.44% | 3 | May 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $51 | $46.38 | +9.96% | 2 | May 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $59 → $49 | $48.95 | +0.10% | 5 | Apr 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $36.23 | +24.21% | 1 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $67 | $56.12 | +19.39% | 2 | Mar 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $7.5 | $2.70 | +177.78% | 5 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $94 | $100.55 | -6.51% | 1 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $14 | $10.03 | +39.58% | 2 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $18.26 | -12.38% | 5 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $34 | $36.58 | -7.05% | 1 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $179 | $204.38 | -12.42% | 1 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $6.08 | - | 2 | May 7, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $8.70 | - | 5 | Nov 6, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.25 | - | 2 | Jul 10, 2017 |
Healthcare Realty Trust
May 5, 2025
Maintains: Neutral
Price Target: $18 → $16
Current: $15.76
Upside: +1.52%
Healthpeak Properties
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $22
Current: $17.36
Upside: +26.73%
Safehold
Apr 1, 2025
Reiterates: Neutral
Price Target: $20
Current: $15.76
Upside: +26.90%
National Health Investors
Mar 17, 2025
Reiterates: Outperform
Price Target: $88
Current: $70.84
Upside: +24.22%
CareTrust REIT
Mar 14, 2025
Reiterates: Underperform
Price Target: $26
Current: $30.60
Upside: -15.03%
Strawberry Fields REIT
Mar 5, 2025
Maintains: Outperform
Price Target: $12 → $14
Current: $11.07
Upside: +26.47%
Ventas
Feb 14, 2025
Maintains: Outperform
Price Target: $69 → $78
Current: $62.88
Upside: +24.05%
Welltower
Feb 14, 2025
Upgrades: Outperform
Price Target: $145 → $167
Current: $152.13
Upside: +9.77%
UMH Properties
Jan 13, 2025
Reiterates: Neutral
Price Target: $20
Current: $16.73
Upside: +19.55%
Douglas Emmett
Jan 2, 2025
Upgrades: Outperform
Price Target: $19 → $21
Current: $15.19
Upside: +38.25%
Jan 2, 2025
Downgrades: Underperform
Price Target: $81 → $70
Current: $68.60
Upside: +2.04%
Jan 2, 2025
Upgrades: Outperform
Price Target: $34 → $33
Current: $32.28
Upside: +2.23%
Dec 17, 2024
Initiates: Neutral
Price Target: $72
Current: $60.06
Upside: +19.88%
Dec 6, 2024
Maintains: Neutral
Price Target: $120 → $110
Current: $73.37
Upside: +49.93%
Oct 25, 2024
Reiterates: Outperform
Price Target: $209
Current: $167.55
Upside: +24.74%
Sep 20, 2024
Reiterates: Outperform
Price Target: $40
Current: $34.51
Upside: +15.91%
Aug 5, 2024
Maintains: Outperform
Price Target: $118 → $131
Current: $113.76
Upside: +15.15%
Aug 5, 2024
Maintains: Neutral
Price Target: $68 → $75
Current: $67.35
Upside: +11.36%
Aug 5, 2024
Maintains: Neutral
Price Target: $264 → $301
Current: $285.41
Upside: +5.46%
Aug 5, 2024
Maintains: Outperform
Price Target: $45 → $49
Current: $40.71
Upside: +20.36%
Aug 5, 2024
Maintains: Outperform
Price Target: $44 → $45
Current: $36.20
Upside: +24.31%
Aug 5, 2024
Maintains: Outperform
Price Target: $28 → $33
Current: $27.77
Upside: +18.83%
Aug 5, 2024
Maintains: Outperform
Price Target: $154 → $184
Current: $147.85
Upside: +24.45%
May 30, 2024
Reiterates: Outperform
Price Target: $22
Current: $15.76
Upside: +39.59%
May 28, 2024
Reiterates: Neutral
Price Target: $17
Current: $10.53
Upside: +61.44%
May 17, 2024
Reiterates: Outperform
Price Target: $51
Current: $46.38
Upside: +9.96%
Apr 25, 2024
Downgrades: Neutral
Price Target: $59 → $49
Current: $48.95
Upside: +0.10%
Apr 22, 2024
Initiates: Neutral
Price Target: $45
Current: $36.23
Upside: +24.21%
Mar 28, 2024
Reiterates: Neutral
Price Target: $67
Current: $56.12
Upside: +19.39%
Feb 20, 2024
Downgrades: Neutral
Price Target: $11 → $7.5
Current: $2.70
Upside: +177.78%
Oct 3, 2023
Initiates: Outperform
Price Target: $94
Current: $100.55
Upside: -6.51%
Oct 3, 2023
Initiates: Neutral
Price Target: $14
Current: $10.03
Upside: +39.58%
Oct 3, 2023
Initiates: Outperform
Price Target: $16
Current: $18.26
Upside: -12.38%
Oct 3, 2023
Initiates: Neutral
Price Target: $34
Current: $36.58
Upside: -7.05%
Oct 3, 2023
Initiates: Neutral
Price Target: $179
Current: $204.38
Upside: -12.42%
May 7, 2018
Upgrades: Neutral
Price Target: n/a
Current: $6.08
Upside: -
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $8.70
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $4.25
Upside: -